Evidence map›Paper›PMID 19381274›Full record

ArticlePloS one2009

Unc119 protects from Shigella infection by inhibiting the Abl family kinases.

Ramarao Vepachedu, Zunayet Karim, Ojas Patel, Nicholas Goplen, Rafeul Alam

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Ramarao VepacheduNational Jewish Health, Denver, CO, USA.
Zunayet Karim
Ojas Patel
Nicholas Goplen
Rafeul Alam
National Jewish Health · USDenver Health Medical Center · USUniversity of Colorado Denver · USUniversity of Colorado Health · US

Funding

Signaling Memory in Chronic AsthmaP01HL036577 · NHLBI · NATIONAL JEWISH HEALTH · PI GELFAND, ERWIN WILLIAM · 1986 to 2011
$18.7M
The Role of Unc119 in T Cell Antigen Receptor Signaling1R01AI059719 · NIAID · NATIONAL JEWISH HEALTH · PI ALAM, RAFEUL · 2004 to 2008
$1.8M
The Importance of the p38 MAP Kinase Signaling Pathways in AsthmaR01AI068088 · NIAID · NATIONAL JEWISH HEALTH · PI ALAM, RAFEUL · 2005 to 2008
$1.5M
NHLBI NIH HHS HL 36577NHLBI NIH HHS P01 HL036577NIAID NIH HHS AI68088NIAID NIH HHS HHSN272200700048CNIAID NIH HHS R01 AI059719NIAID NIH HHS R01 AI068088PHS HHS N01 HHSN 272200700048C
6 · The paper itself

Abstract

backgroundBacteria engage cell surface receptors and intracellular signaling molecules to enter the cell. Unc119 is an adaptor protein, which interacts with receptors and tyrosine kinases. Its role in bacterial invasion of cells is unknown. METHODOLOGY/PRINCIPAL

findingsWe used biochemical, molecular and cell biology approaches to identify the binding partners of Unc119, and to study the effect of Unc119 on Abl family kinases and Shigella infection. We employed loss-of-function and gain-in-function approaches to study the effect of Unc119 in a mouse model of pulmonary shigellosis. Unc119 interacts with Abl family kinases and inhibits their kinase activity. As a consequence, it inhibits Crk phosphorylation, which is essential for Shigella infection. Unc119 co-localizes with Crk and Shigella in infected cells. Shigella infectivity increases in Unc119-deficient epithelial and macrophage cells. In a mouse model of shigellosis cell-permeable TAT-Unc119 inhibits Shigella infection. Conversely, Unc119 knockdown in vivo results in enhanced bacterial invasion and increased lethality. Unc119 is an inducible protein. Its expression is upregulated by probacteria and bacterial products such as lipopolysacharide and sodium butyrate. The latter inhibits Shigella infection in mouse lungs but is ineffective in Unc119 deficiency.

conclusionsUnc119 inhibits signaling pathways that are used by Shigella to enter the cell. As a consequence it provides partial but significant protection from Shigella infections. Unc119 induction in vivo boosts host defense against infections.

Indexed as

Adaptor Proteins, Signal TransducingAmino Acid SequenceAnimalsBase SequenceCell LineDisease Models, AnimalDysentery, BacillaryEnzyme ActivationHumansIntracellular Signaling Peptides and ProteinsMiceMicroscopy, FluorescenceMicrotubule ProteinsProtein KinasesRNA, Small InterferingAdaptor Proteins, Signal TransducingIntracellular Signaling Peptides and ProteinsMicrotubule ProteinsProtein KinasesRNA, Small InterferingUnc119 protein, mouse

Identifiers

PMID19381274
PMCPMC2667249
OpenAlexW2069253583

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.